1
|
Luo Z, Chen C, Gan Q, Wan R, Hong Z, Zhu M, Wu X, Sha L, Chen Y, He Y, Feng X, Liang J, Chen S, Zhou X. SportSync health: revolutionizing patient care in sports medicine through integrated follow-up technologies. BURNS & TRAUMA 2024; 12:tkae064. [PMID: 39497834 PMCID: PMC11534349 DOI: 10.1093/burnst/tkae064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Accepted: 10/08/2024] [Indexed: 11/07/2024]
Affiliation(s)
- Zhiwen Luo
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Chen Chen
- Department of Arthroscopic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Road, Shanghai, 200233, China
| | - Quan Gan
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Renwen Wan
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Zhenghua Hong
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Min Zhu
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Xiaohan Wu
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Linlin Sha
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Yisheng Chen
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Yanwei He
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Xingting Feng
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Junbo Liang
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| | - Shiyi Chen
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
| | - Xiaobo Zhou
- Department of Sports Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, No. 150 Ximen Street, Zhejiang, China
| |
Collapse
|
2
|
Weng X, Yin H, Liu K, Song C, Xie J, Guo N, Wang MP. Chatbot-Led Support Combined With Counselor-Led Support on Smoking Cessation in China: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc 2024; 13:e58636. [PMID: 39312291 PMCID: PMC11459100 DOI: 10.2196/58636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Revised: 07/19/2024] [Accepted: 08/14/2024] [Indexed: 09/25/2024] Open
Abstract
BACKGROUND China has a large population of smokers, with half of them dependent on tobacco and in need of cessation assistance, indicating the need for mobile health (mHealth) to provide cessation support. OBJECTIVE The study aims to assess the feasibility and preliminary effectiveness of combining chatbot-led support with counselor-led support for smoking cessation among community smokers in China. METHODS This is a 2-arm, parallel, assessor-blinded, pilot randomized controlled trial nested in a smoke-free campus campaign in Zhuhai, China. All participants will receive brief face-to-face cessation advice and group cessation support led by a chatbot embedded in WeChat. In addition, participants in the intervention group will receive personalized WeChat-based counseling from trained counselors. Follow-up will occur at 1, 3, and 6 months after treatment initiation. The primary smoking outcome is bioverified abstinence (exhaled carbon monoxide <4 parts per million or salivary cotinine <30 ng/mL) at 6 months. Secondary outcomes include self-reported 7-day point prevalence of abstinence, smoking reduction rate, and quit attempts. Feasibility outcomes include eligibility rate, consent rate, intervention engagement, and retention rate. An intention-to-treat approach and regression models will be used for primary analyses. RESULTS Participant recruitment began in March 2023, and the intervention began in April 2023. The data collection was completed in June 2024. The results of the study will be published in peer-reviewed journals and presented at international conferences. CONCLUSIONS This study will provide novel insights into the feasibility and preliminary effectiveness of a chatbot-led intervention for smoking cessation in China. The findings of this study will inform the development and optimization of mHealth interventions for smoking cessation in China and other low- and middle-income countries. TRIAL REGISTRATION ClinicalTrials.gov NCT05777005; https://clinicaltrials.gov/study/NCT05777005. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/58636.
Collapse
Affiliation(s)
- Xue Weng
- Institute of Advanced Studies in Humanities and Social Sciences, Beijing Normal University, Zhuhai, China
| | - Hua Yin
- Office of Clinical Research Administration, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China
| | - Kefeng Liu
- Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Zhuhai, China
| | - Chuyu Song
- School of Sociology, Beijing Normal University, Beijing, China
| | - Jiali Xie
- School of Sociology, Beijing Normal University, Beijing, China
| | - Ningyuan Guo
- School of Nursing, Shanghai Jiao Tong University, Shanghai, China
| | - Man Ping Wang
- LKS Faculty of Medicine, School of Nursing, The University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|
3
|
Liu S, Zhou H, He W, Yang J, Yin X, Shalayiding S, Ren N, Zhou Y, Rao X, Zhang N, Xiong M, Wang Y, Yang W, Wu Y, Chen J. Risk profiling of tobacco epidemic and estimated number of smokers living in China: a cross-sectional study based on PBICR. BMC Public Health 2024; 24:2219. [PMID: 39148035 PMCID: PMC11325620 DOI: 10.1186/s12889-024-18559-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 04/09/2024] [Indexed: 08/17/2024] Open
Abstract
BACKGROUND Evidence on the prevalence of smoking in China remains insufficient, with most previous studies focusing on a single region. However, smoking prevalence exhibits significant inequalities across the entire country. This study aimed to evaluate the risk of tobacco prevalence across the country, taking into account spatial inequalities. METHODS The data used in this study were collected in 23 provinces, 5 autonomous regions, and 4 municipalities directly under the central government in 2022. Large population survey data were used, and a Bayesian geostatistical model was employed to investigate smoking prevalence rates across multiple spatial domains. FINDINGS Significant spatial variations were observed in smokers and exposure to secondhand smoke across China. Higher levels of smokers and secondhand smoke exposure were observed in western and northeastern regions. Additionally, the autonomous region of Tibet, Shanghai municipality, and Yunnan province had the highest prevalence of smokers, while Tibet, Qinghai province, and Yunnan province had the highest prevalence of exposure to secondhand smoke. CONCLUSION We have developed a model-based, high-resolution nationwide assessment of smoking risks and employed rigorous Bayesian geostatistical models to help visualize smoking prevalence predictions. These prediction maps provide estimates of the geographical distribution of smoking, which will serve as strong evidence for the formulation and implementation of smoking cessation policies. HIGHLIGHTS Our study investigated the prevalence of smokers and exposure to secondhand smoke in different spatial areas of China and explored various factors influencing the smoking prevalence. For the first time, our study applied Bayesian geostatistical modeling to generate a risk prediction map of smoking prevalence, which provides a more intuitive and clear understanding of the spatial disparities in smoking prevalence across different geographical regions, economic levels, and development status. We found significant spatial variations in smokers and secondhand smoke exposure in China, with higher rates in the western and northeastern regions.
Collapse
Affiliation(s)
- Siyuan Liu
- School of Public Health, Southern Medical University, Guangzhou510515, Guangzhou510515, China
| | - Haozheng Zhou
- School of Public Health, Southern Medical University, Guangzhou510515, Guangzhou510515, China
| | - Wenjun He
- School of Public Health, Southern Medical University, Guangzhou510515, Guangzhou510515, China
| | - Jiao Yang
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Xuanhao Yin
- School of Public Health, Southern Medical University, Guangzhou510515, Guangzhou510515, China
| | - Sufelia Shalayiding
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Na Ren
- Institute of Chinese Medical Sciences, University of Macau, Macau, China
- Operation Management Department, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, China
| | - Yan Zhou
- Operation Management Department, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, China
| | - Xinyi Rao
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Nuofan Zhang
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Man Xiong
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Yueying Wang
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Wenfu Yang
- School of Health Management, Southern Medical University, Guangzhou510515, China
| | - Yibo Wu
- School of Public Heath, Peking University, Beijing100091, China.
| | - Jiangyun Chen
- School of Public Health, Southern Medical University, Guangzhou510515, Guangzhou510515, China.
- School of Health Management, Southern Medical University, Guangzhou510515, China.
| |
Collapse
|
4
|
Chu S, Jing H, Zhang D, Cao Y, Qian Y, Liu X, Xiao L, Tong Z, Liang L. Comparative Effectiveness of Mobile Health-Based Comprehensive Smoking Cessation Modalities and Traditional Clinic-Delivered Treatments - Beijing Municipality, China, May 2022 to April 2024. China CDC Wkly 2024; 6:516-521. [PMID: 38855571 PMCID: PMC11154100 DOI: 10.46234/ccdcw2024.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2023] [Accepted: 05/21/2024] [Indexed: 06/11/2024] Open
Abstract
What is already known about this topic? Most Chinese smokers have not accessed professional help due to a lack of sufficient smoking cessation services. Mobile health (mHealth) can mitigate obstacles related to time and transportation, thereby providing effective support for smokers seeking to quit. What is added by this report? This study offers real-world evidence supporting the effectiveness of mHealth-based comprehensive smoking cessation interventions. The findings indicate that these modalities can significantly enhance abstinence rates, albeit to a lesser extent compared to traditional clinic-based treatments. Adherence to the intervention was identified as a critical factor influencing the effectiveness of smoking cessation strategies. What are the implications for public health practice? The mHealth-based comprehensive smoking cessation modalities, with or without mailing cessation medications, present a promising approach to enhancing access to and utilization of smoking cessation services. This strategy addresses the significant challenge of limited smoking cessation resources in China.
Collapse
Affiliation(s)
- Shuilian Chu
- Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
| | - Hang Jing
- Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
| | - Di Zhang
- Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
| | - Yuan Cao
- Beijing Center for Disease Prevention and Control, Beijing, China
| | - Yunliang Qian
- Beijing Center for Disease Prevention and Control, Beijing, China
| | - Xiurong Liu
- Beijing Center for Disease Prevention and Control, Beijing, China
| | - Lin Xiao
- Tobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Zhaohui Tong
- Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
| | - Lirong Liang
- Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
| |
Collapse
|
5
|
Cheng A, Liu Z, Zhou X, Su Z, Xiao D, Wang C, China National Tobacco Cessation Cohort Study (CNTCCS) Study Group T. Real-World Treatment Adherence to Smoking Cessation Medications and Association with Treatment Outcome - 27 Centers, China, 2017-2022. China CDC Wkly 2024; 6:522-529. [PMID: 38855569 PMCID: PMC11154102 DOI: 10.46234/ccdcw2024.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 05/16/2024] [Indexed: 06/11/2024] Open
Abstract
What is already known about this topic? Medication non-adherence significantly impedes smoking cessation efforts. While effective smoking cessation medications are accessible in China, real-world adherence and its correlation with treatment outcomes remain largely unexplored. What is added by this report? From December 2017 to January 2022, 1,120 participants were recruited from 27 centers in all seven geographical regions of China. Results revealed that only 38.2% of smokers adhered to the prescribed 12-week smoking cessation treatment and those with a higher education level were more likely to be adherent. In addition, smokers with good adherence were more likely to successfully quit smoking. What are the implications for public health practice? The data obtained could enhance our understanding of smoking cessation practices in China. Improving adherence is a crucial strategy to enhance the effectiveness of smoking cessation treatments and management provided to smokers.
Collapse
Affiliation(s)
- Anqi Cheng
- Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; National Center for Respiratory Medicine; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Zhao Liu
- Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; National Center for Respiratory Medicine; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Xinmei Zhou
- Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; National Center for Respiratory Medicine; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Zheng Su
- Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; National Center for Respiratory Medicine; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Dan Xiao
- Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; National Center for Respiratory Medicine; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Chen Wang
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention; China National Center for Respiratory Medicine; China National Clinical Research Center for Respiratory Diseases, Beijing, China
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | | |
Collapse
|
6
|
Zhang C, Yu L, Xiong T, Zhang Y, Liu J, Zhang J, He P, Xi Y, Jiang Y. Exploring a Potential Causal Link Between Dietary Intake and Chronic Obstructive Pulmonary Disease: A Two-Sample Mendelian Randomization Study. Int J Chron Obstruct Pulmon Dis 2024; 19:297-308. [PMID: 38292139 PMCID: PMC10826572 DOI: 10.2147/copd.s445706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Accepted: 01/14/2024] [Indexed: 02/01/2024] Open
Abstract
Background Chronic Obstructive Pulmonary Disease (COPD), the most prevalent chronic respiratory condition, significantly impairs patients' quality of life. The pivotal element in disease management lies in prevention, underscoring the paramount importance of employing a scientific approach to investigate early prevention strategies for COPD. Methods This study delved into the causal link between 28 dietary intakes and COPD employing two-sample Mendelian randomization. We primarily utilized the Inverse Variance Weighted (IVW) method as the main outcome, complemented by Weighted Median (WM), MR-Egger method, along with several sensitivity analysis techniques, all accompanied by visual representations. Results We identified higher odds of COPD following exposure to green beans (OR=1.381, 95% CI=1.119-1.704, P=0.003) and pork intake (OR=2.657, 95% CI=1.203-5.868, P=0.016). In contrast, the odds of developing COPD were lower following exposure to dried fruit (OR=0.481, 95% CI=0.283-0.819, P=0.007), cereal (OR=0.560, 95% CI=0.356-0.880, P=0.012), and whole egg consumption (OR=0.700, 95% CI=0.504-0.972, P=0.033). Conclusion In light of our study's findings, we anticipate that strategically modifying dietary choices may offer an avenue for early COPD prevention in the future.
Collapse
Affiliation(s)
- Chenwei Zhang
- Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
- The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Lu Yu
- Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
- The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Tao Xiong
- The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Yukai Zhang
- The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Juan Liu
- Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Jingfen Zhang
- Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Peiyun He
- Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Yujia Xi
- Department of Urology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| | - Yi Jiang
- Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
- NHC Key Laboratory of Pneumoconiosis, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China
| |
Collapse
|